Seyed Farzad Maroufi, Parnian Shobeiri, Esmaeil Mohammadi, Sina Azadnajafabad, Mohammad-Reza Malekpour, Erfan Ghasemi, Mohammad-Mahdi Rashidi, Sahar Saeedi Moghaddam, Nazila Rezaei, Yeganeh Sharifnejad Tehrani, Sahar Mohammadi Fateh, Naser Ahmadi, Yosef Farzi, Negar Rezaei, Bagher Larijani
BACKGROUND: Multiple sclerosis (MS) is a common neurologic autoimmune disorder. We have used a newly introduced measure, Quality of Care Index (QCI), which is associated with the efficacy of care given to patients suffering from MS. OBJECTIVE: To report and compare the quality of care given to MS patients in different regions and country. METHOD: Primary measures were retrieved from Global Burden of Disease (GBD) from 1990 to 2019. Secondary measures (mortality to incidence ratio, DALY to prevalence ratio, prevalence to incidence ratio, and YLL to YLD ratio) were combined using Principle Component Analysis (PCA), to form an essential component (QCI) (0-100 index with higher values representing better condition)...
September 21, 2023: Neuroepidemiology